NanoViricides
NNVC
#10132
Rank
$22.13 M
Marketcap
$1.23
Share price
0.82%
Change (1 day)
-15.75%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -$0.67

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -$0.67. In 2024 the company made an earnings per share (EPS) of -$0.70 an increase over its 2023 EPS that were of -$0.74.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.67-4.29%
2024-$0.70-5.41%
2023-$0.745.71%
2022-$0.70-13.58%
2021-$0.81-66.11%
2020-$2.391.7%
2019-$2.35-10.98%
2018-$2.64-22.35%
2017-$3.40-10.53%
2016-$3.80375%
2015-$0.80-85.19%
2014-$5.4042.11%
2013-$3.8026.67%
2012-$3.00-6.25%
2011-$3.2014.28%
2010-$2.80100%
2009-$1.40-0%
2008-$1.40-33.33%
2007-$2.10-0%
2006-$2.104445.07%
2005-$0.04620

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-$0.05000-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$2.12-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$6.52-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$2.97-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.59-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$3.60-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK